Boston Advisors’s Phibro Animal Health PAHC Stock Holding History

Boston Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-9,220	Closed	-$425K	–	667
2018 Q2	$425K	Buy	+9,220	New	+$408K	0.01%	521

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVA

Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Boston Advisors's PAHC Position: Q3 2018 in Review

Boston Advisors sold out of Phibro Animal Health (PAHC) in Q3 2018, closing a stake of 9,220 shares — an estimated $425K sold.

Boston Advisors first reported a position in PAHC in Q2 2018 and held it in 1 quarter. The position peaked at $425K in Q2 2018. 191 funds tracked by Wall St. Rank hold PAHC as of Q3 2018.

Boston Advisors reported no remaining Phibro Animal Health position as of Q3 2018 after selling out during the quarter.
Boston Advisors sold 9,220 Phibro Animal Health shares in Q3 2018, an estimated $425K.
Boston Advisors first reported a position in Phibro Animal Health in Q2 2018 and held it in 1 quarter.
Boston Advisors's Phibro Animal Health position peaked at $425K in Q2 2018.
191 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2018.

Based on Boston Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.